Meyer Andrew Hollman sold JANX
October 28, 2025 · Form 4 insider transaction
Meyer Andrew Hollman sold 16,665 shares of Janux Therapeutics, Inc. at $30.06 per share, a transaction worth $501.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
16,665
Price
$30.06
Total value
$501.0K
InsiderMeyer Andrew Hollman
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 28, 2025
Filing dateOctober 30, 2025
Shares owned after82,139
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024.; The weighted average sale price for the transaction reported was $30.0622 and the range of prices were between $30.00 and $30.49. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.